Arizona Urology Adopts AI Mapping to Refine Prostate Cancer Care

The platform, developed by Avenda Health, generates personalized 3D maps that visualize tumor boundaries with high accuracy. While traditional MRI methods can underestimate the spread of cancer, research indicates that Unfold AI increases the sensitivity of tumor identification from 37% to 97%. This granular data helps surgeons perform robotic prostatectomies with greater precision, allowing them to better preserve a patient's urinary and erectile function.

For the clinical team at Arizona Urology, where prostate cancer accounts for 40% of their caseload, the technology serves as more than a diagnostic tool. It acts as a visual guide during patient counseling, demystifying the disease for those who may travel from rural communities for specialized care. Dr. Pankaj Jain of Arizona Urology noted that the software removes the abstraction of cancer staging, enabling physicians to make more informed surgical decisions.

Beyond surgical planning, the practice intends to use the platform to identify candidates for outpatient focal therapy. Adoption is supported by an established reimbursement framework, as Unfold AI is the first urology-focused AI tool to receive a Category III CPT code from the American Medical Association. With Medicare coverage now available in the region, the partnership aims to standardize high-level cancer mapping within community-based private practices.